This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Immune Response BioPharma, Inc.
Drug Names(s): Remune
Description: REMUNE, an HIV-specific immune-based therapy under development, is a proprietary formulation of modified, killed HIV that is designed to stimulate T cells to produce an immune response to HIV-specific antigen. It is hoped that this enhanced immune response will help to control infection and consequently slow the progression to AIDS.
Additional information available to subscribers only: